Solazyme Inc. (NASDAQ: SZYM) reported its fourth-quarter financial results after the markets closed on Monday. The company said it had a net loss of $0.32 per share on $10.4 million in revenue, compared to consensus estimates from Thomson Reuters that called for a net loss of $0.43 per share on $11.33 million in revenue. The same period from the previous year had a net loss of $0.45 per share on $14.50 million in revenue.
Separately, the company announced that it signed a definitive multiyear global supply agreement with Unilever. The five-year, multi-oil supply agreement provides for Unilever to purchase renewable algae oils for use in personal care products and is expected to represent total revenue of more than $200 million over the term of the agreement.
This agreement follows last week’s announcement that Solazyme is refining its business to focus on food, nutrition and specialty ingredients, harnessing the power of its transformational algae innovation platform. Solazyme has been renamed “TerraVia” to reflect this focus and the journey to improve the lives of people and the planet.
Jonathan Wolfson, CEO, commented:
As announced last week, we are moving forward with a refined focus on our food, nutrition and specialty ingredients portfolio, and we are actively transitioning to the TerraVia banner. Today’s important announcement with Unilever, in conjunction with the recent expansion of our joint venture with Bunge into sustainable and healthier foods, shows that the two companies who know us best are reaffirming and expanding their commitments with us, representing further validation of our products, manufacturing capabilities, cost structure and sustainability profile. In an era when most of the innovation taking place in food is in the reformulation, repackaging, and marketing of existing products and ingredients, we are different in that we have built and offer true innovation with new, and unique ingredients based on algae, the mother of all plants, and earth’s original superfood. As TerraVia, we are today uniquely positioned to bring algae into the mainstream in food, nutrition and specialty ingredients.
On the books, cash, cash equivalents and marketable securities totaled $97.98 million at the end of the quarter, compared to $207.31 million in the same period last year.
Shares of Solazyme closed Monday down 4.5% at $1.90, with a consensus analyst price target of $3.17 and a 52-week trading range of $1.18 to $4.74. Following the release of the earnings report, the stock was up nearly 37% at $2.60.
Travel Cards Are Getting Too Good To Ignore
Credit card companies are pulling out all the stops, with the issuers are offering insane travel rewards and perks.
We’re talking huge sign-up bonuses, points on every purchase, and benefits like lounge access, travel credits, and free hotel nights. For travelers, these rewards can add up to thousands of dollars in flights, upgrades, and luxury experiences every year.
It’s like getting paid to travel — and it’s available to qualified borrowers who know where to look.
We’ve rounded up some of the best travel credit cards on the market. Click here to see the list. Don’t miss these offers — they won’t be this good forever.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.